Michigan Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 33 (85% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 12,540
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 43.63%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 4,728
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 48.49%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 50.10% 45.47%
White, Hispanic/Latino Patients 5.95% 7.47%
Black/African American, Non-Hispanic/Latino Patients 22.60% 24.56%
Black/African American, Hispanic/Latino Patients 0.65% 0.78%
Asian Patients3 1.27% 1.21%
American Indian/Alaska Native Patients3 0.42% 0.42%
Native Hawaiian/Other Pacific Islander Patients3 0.27% 0.19%
Patients with More Than One Race3 2.61% 2.58%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.01% 5.60%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.34% 1.92%
Unreported/Refused to Report Race and Ethnicity 8.77% 9.79%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 2,895
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 63.00%
COVID-19 Immunization Series Completed 2,088
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 66.02%
COVID-19 Immunization Series Additional 4,831
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 51.88%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 32.30% 29.55% 43.12%
White, Hispanic/Latino Patients 14.20% 14.56% 7.49%
Black/African American, Non-Hispanic/Latino Patients 18.03% 17.91% 16.54%
Black/African American, Hispanic/Latino Patients 1.42% 2.11% 0.41%
Asian Patients3 1.45% 0.81% 1.55%
American Indian/Alaska Native Patients3 0.69% 0.34% 4.10%
Native Hawaiian/Other Pacific Islander Patients3 0.24% 0.14% 0.19%
Patients with More Than One Race3 3.32% 4.26% 1.53%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 15.65% 17.29% 14.68%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.83% 2.30% 1.80%
Unreported/Refused to Report Race and Ethnicity 10.88% 10.73% 8.59%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 12.12%
1 to 24 Hours 15.15%
More Than 24 Hours 72.73%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 63.64%
Vaccine confidence 36.36%
Vaccine storage capacity 0.00%
Vaccine supply 9.09%
Other 9.09%
None 15.15%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 18.18%
Average Percent of Health Center Visits Conducted Virtually 20.91%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 57.58%
Number of Mobile Van Sites 16
Number of Pop-up Clinics 27
Number of School-Based Vaccination Sites 5
Number of Family Vaccination Clinics 81

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 9.09%
Refer patients to another organization that provides monoclonal antibody therapies 66.67%
None 27.27%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 12.12%
Patient awareness/education 3.03%
Staffing capacity 12.12%
Therapy administration/onsite logistics 9.09%
Other 0.00%
None 72.73%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 16
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 20,208

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 75.00%
Provide to General Public Who Came to the Health Center 75.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 37.50%
Provide at Other Community Events 37.50%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 12.50%
Other 37.50%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 4
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 23.08%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 61.54%
White, Hispanic/Latino Patients 15.38%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.69%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 7.69%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022